| Literature DB >> 34828313 |
Sichong Peng1, Jessica L Petersen2, Rebecca R Bellone1,3, Ted Kalbfleisch4, N B Kingsley1,3, Alexa M Barber2, Eleonora Cappelletti5, Elena Giulotto5, Carrie J Finno1.
Abstract
The horse reference genome assemblies, EquCab2.0 and EquCab3.0, have enabled great advancements in the equine genomics field, from tools to novel discoveries. However, significant gaps of knowledge regarding genome function remain, hindering the study of complex traits in horses. In an effort to address these gaps and with inspiration from the Encyclopedia of DNA Elements (ENCODE) project, the equine Functional Annotation of Animal Genome (FAANG) initiative was proposed to bridge the gap between genome and gene expression, providing further insights into functional regulation within the horse genome. Three years after launching the initiative, the equine FAANG group has generated data from more than 400 experiments using over 50 tissues, targeting a variety of regulatory features of the equine genome. In this review, we examine how valuable lessons learned from the ENCODE project informed our decisions in the equine FAANG project. We report the current state of the equine FAANG project and discuss how FAANG can serve as a template for future expansion of functional annotation in the equine genome and be used as a reference for studies of complex traits in horse. A well-annotated reference functional atlas will also help advance equine genetics in the pan-genome and precision medicine era.Entities:
Keywords: FAANG; epigenetics; functional annotation; gene regulation; health; horse; transcriptome; welfare
Mesh:
Year: 2021 PMID: 34828313 PMCID: PMC8625040 DOI: 10.3390/genes12111707
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Overview of Available Data and Assay Details.
| Project Accession | Assay | Samples | Tissues | Instrument | Library Layout | Number of Experiments |
|---|---|---|---|---|---|---|
| PRJEB26698 | WGS | Two females | 1 | HiSeq 2500 | 2 × 250 bp | 2 |
| PRJEB42407 | WGS | Two males | 1 | NovaSeq 6000 | 2 × 150 bp | 2 |
| PRJEB26787 | RNA-seq | Two females | 30 | HiSeq 2500 | 2 × 250 bp | 60 |
| PRJEB32645 | RRBS | Two females | 10 | HiScanSQ | 1 × 50 bp | 20 |
| PRJEB35307 | Histone ChIP-seq | Two females | 8 | HiSeq 4000 | 1 × 50 bp | 80 |
| PRJEB42315 | Histone ChIP-seq | Two females | 4 | HiSeq 4000 | 1 × 50 bp | 38 |
| PRJEB41079 | CTCF ChIP-seq | Two females | 8 | HiSeq 4000 | 1 × 50 bp | 28 |
| PRJEB41317 | ATAC-seq pilot | Two females | 2 | HiSeq 4000/NextSeq 500 | 2 × 75 bp/2 × 42 bp | 16 |
WGS: whole-genome sequencing; RNA-seq: mRNA sequencing; RRBS: reduced-representation bisulfite sequencing; Histone ChIP-seq: chromatin immunoprecipitation using sequencing for the four major histone marks; CTCF ChIP-seq: chromatin immunoprecipitation using sequencing for CTCF protein; ATAC-seq pilot: assay for transposase accessibility using sequencing.
Overview of Completed Assays.
| Assay | Animals | Tissue Types | Total Experiments |
|---|---|---|---|
| WGS | AH1-AH4 | Blood | 4 |
| mRNA-seq | AH1 | 47 | 140 |
| AH2 | 46 | ||
| AH3 | 23 | ||
| AH4 | 24 | ||
| Iso-seq | AH1–AH4 | 12 | 48 |
| ChIP-seq–H3K4me1 | AH1–AH2 | 12 | 40 |
| AH3–AH4 | 8 | ||
| ChIP-seq–H3K4me3 | AH1–AH2 | 12 | 40 |
| AH3–AH4 | 8 | ||
| ChIP-seq–H3K27ac | AH1–AH2 | 12 | 40 |
| AH3–AH4 | 8 | ||
| ChIP-seq–H3K27me3 | AH1–AH2 | 12 | 40 |
| AH3–AH4 | 8 | ||
| ChIP-seq–CTCF | AH1–AH2 | 8 | 32 |
| AH3–AH4 | 8 | ||
| ATAC-seq | AH1–AH4 | 10 | 40 |
| RRBS | AH1–AH2 | 10 | 20 |
| smRNA-seq | AH1–AH2 | 48 | 96 |
| Total | 48 | 444 | |